Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma

Characterization of exosomes in peritoneal fluid of endometriosis patients

(2020) Hannah M. Nazri et al.   FERTILITY AND STERILITY

Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer

(2020) Xinyi Wang et al.   Molecular Oncology

Circular RNAs: Potential Regulators of Treatment Resistance in Human Cancers

(2020) Shivapriya Jeyaraman et al.   Frontiers in Genetics

Communication in tiny packages: Exosomes as means of tumor-stroma communication

(2020) Juliane Daßler-Plenker et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Breast cancer-derived exosomes: Tumor progression and therapeutic agents

(2020) Nasrollah Jabbari et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Negative symptoms in schizophrenia: Modeling the role of experience factor and expression factor

(2020) Hiroki Okada et al.   Asian Journal of Psychiatry

Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma

(2020) Chenyu Ding et al.   CANCER LETTERS

Tumor Treating Fields in the Management of Patients with Malignant Gliomas

(2020) Ashley P. Ghiaseddin et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

The Biological Role of Sponge Circular RNAs in Gastric Cancer: Main Players or Coadjuvants?

(2020) Adenilson Leão Pereira et al.   Cancers

Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)

(2020) Weijun Hong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Emerging Function and Clinical Significance of Exosomal circRNAs in Cancer

(2020) Man Wang et al.   Molecular Therapy-Nucleic Acids

New Advances of Heparanase and Heparanase-2 in Human Diseases

(2019) Hao Jin et al.   ARCHIVES OF MEDICAL RESEARCH

Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer

(2019) Bhagyashri Kulkarni et al.   DRUG DISCOVERY TODAY

Exosomes and their role in tumorigenesis and anticancer drug resistance

(2019) Neta Milman et al.   DRUG RESISTANCE UPDATES

Implications of exosomes as diagnostic and therapeutic strategies in cancer

(2019) Ali Aghebati‐Maleki et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Exosomes regulate neurogenesis and circuit assembly

(2019) Pranav Sharma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cisplatin-resistant MDA-MB-231 cell-derived exosomes increase the resistance of recipient cells in an exosomal miR-423-5p-dependent manner

(2019) Bing Wang et al.   CURRENT DRUG METABOLISM

Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus

(2019) Wenguang Chang et al.   Cells

Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation

(2019) Lei Yan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance

(2019) Meshach Asare-Werehene et al.   ONCOGENE

Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer

(2019) Kha Wai Hon et al.   Scientific Reports

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

(2018) Xiao Fu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression

(2018) Israel Vlodavsky et al.   TRENDS IN BIOCHEMICAL SCIENCES

The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway

(2018) Linwei Jia et al.   OncoTargets and Therapy

Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma

(2018) Israel López-Valero et al.   BIOCHEMICAL PHARMACOLOGY

Heparanase: From basic research to therapeutic applications in cancer and inflammation

(2016) Israel Vlodavsky et al.   DRUG RESISTANCE UPDATES

Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases

(2016) Silvia Rivara et al.   Future Medicinal Chemistry

Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival

(2016) Soumi Kundu et al.   MOLECULAR CANCER RESEARCH

c-Myc–miR-29c–REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma

(2015) Hui Luo et al.   BRAIN

Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy

(2015) Anna Shteingauz et al.   CANCER RESEARCH

Tumour exosome integrins determine organotropic metastasis

(2015) Ayuko Hoshino et al.   NATURE

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma

(2015) Vishnu C. Ramani et al.   Oncotarget

Erratum: Borderud SP, Li Y, Burkhalter JE, Sheffer CE and Ostroff JS. Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes.Cancer. doi: 10.1002/cncr.28811

(2014)   CANCER

The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics

(2014) Edward Hammond et al.   Frontiers in Oncology

Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes

(2013) Camilla A. Thompson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis

(2010) Renato V. Iozzo et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY